ArticleFrontiers in nutrition2025
Association between neutrophil percentage-to-albumin ratio and Parkinson's disease amongst adults in the US.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Association Between Neutrophil Percentage-Albumin Ratio and Biological Aging in Rheumatoid Arthritis in the United States: A Cross-Sectional Study of NHANES.Mediators of inflammation · 2026Article
- Establishment and evaluation of a novel tool based on inflammation-nutrition derived biomarkers for early diagnosis of diabetic foot ulcers.Frontiers in immunology · 2026Article
- Association of the Naples prognostic score with Parkinson disease risk: a prospective cohort study.Frontiers in aging neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Inflammation is an important factor in Parkinson's disease (PD). Researchers are exploring the integration of multiple biomarkers, including inflammatory and non-inflammatory markers, to enhance predictive value. Neutrophil percentage-to-albumin ratio (NPAR), a novel inflammatory biomarker, offers economic efficiency and accessibility. However, the association between NPAR and PD remains to be elucidated. Methods: We conducted a cross-sectional study involving participants aged 40 years and above from the National Health and Nutrition Examination Survey (NHANES) database, spanning the years 1999 to 2018. NPAR was calculated as neutrophil percentage (in total white blood cell (WBC) count) (%) × 100/albumin (g/dL). A multivariable logistic regression model was employed to examine the independent association between NPAR and PD while adjusting for demographic factors; educational level; income-to-poverty ratio; smoking status; alcohol consumption; body mass index (BMI); physical activity; and history of hypertension, diabetes, hyperlipidaemia and cardiovascular diseases. Additionally, subgroup analyses were conducted to investigate whether the effect of NPAR varied across different demographic subgroups. Results: The NPAR score demonstrates a significant positive correlation with PD. When examined as a categorical variable, individuals in the highest tertiles of NPAR show a 65% increased prevalence of PD compared to those in the lowest tertiles (odds ratio [OR] 1.65 [95% confidence interval {CI} 1.16, 2.34]). Moreover, weighted restricted cubic spline and threshold effect analyses confirmed a positive association between NPAR and PD, identifying a threshold and saturation effect inflextion point at 9.82. An elevated likelihood of PD development exists beyond the NPAR level of 9.82 (OR 1.12 [95% CI: 1.06, 1.19]). Additionally, subgroup analyses and interaction tests reveal that BMI and hypertension significantly influence the relationship between NPAR and PD ( Conclusion: Our study revealed a positive association between NPAR levels and PD, indicating that high NPAR levels are associated with an increased likelihood of developing PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.